Biktarvy, formally known as biktarvy, includes a powerful single-tablet regimen for treating HIV infection. This formula combines three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by inhibiting the virus's ability to copy within the body, significantly decreasing the viral quantity. For many individua